We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.22B
AUM Growth
+$2.7B
Cap. Flow
+$3.76B
Cap. Flow %
89.24%
Top 10 Hldgs %
40.53%
Holding
623
New
593
Increased
5
Reduced
1
Closed
3

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.36%
3 Technology 18.59%
4 Industrials 5.57%
5 Real Estate 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSNB
126
DELISTED
Fusion Acquisition Corp. II
FSNB
$4.6M 0.11%
+453,837
New +$4.6M
GLPI icon
127
Gaming and Leisure Properties
GLPI
$12.8B
$4.59M 0.11%
+88,192
New +$4.6M
FMIV
128
DELISTED
Forum Merger IV Corporation Class A Common stock
FMIV
$4.55M 0.11%
+447,591
New +$4.53M
OXY icon
129
Occidental Petroleum
OXY
$56B
$4.52M 0.11%
+72,446
New +$4.5M
CCI icon
130
Crown Castle
CCI
$31.9B
$4.51M 0.11%
+33,696
New +$4.66M
SNY icon
131
Sanofi
SNY
$103B
$4.5M 0.11%
+82,648
New +$4.02M
EVLV icon
132
Evolv Technologies
EVLV
$1.07B
$4.42M 0.1%
+1,417,864
New +$4.05M
BMAC
133
DELISTED
Black Mountain Acquisition Corp.
BMAC
$4.42M 0.1%
+425,359
New +$4.38M
ETN icon
134
Eaton
ETN
$174B
$4.28M 0.1%
+25,000
New +$4.16M
PRPC
135
DELISTED
CC Neuberger Principal Holdings III
PRPC
$4.22M 0.1%
+409,413
New +$4.17M
GSK icon
136
GSK
GSK
$104B
$4.21M 0.1%
+118,416
New +$4.14M
BDX icon
137
Becton Dickinson
BDX
$48.8B
$4.15M 0.1%
+16,766
New +$4.1M
BEKE icon
138
KE Holdings
BEKE
$18.7B
$4.15M 0.1%
+220,060
New +$4.07M
NUVA
139
DELISTED
NuVasive, Inc.
NUVA
$4.13M 0.1%
+100,000
New +$4.28M
SBXC.U
140
DELISTED
SilverBox Corp III Units, each consisting of one Class A Common Stock and one-third of one redeemable warrant
SBXC.U
$4.07M 0.1%
+404,961
New +$4.08M
MAA icon
141
Mid-America Apartment Communities
MAA
$15.5B
$4.07M 0.1%
+26,965
New +$4.28M
GVCI
142
DELISTED
Green Visor Financial Technology Acquisition Corp. I Class A Ordinary Shares
GVCI
$3.99M 0.09%
+378,097
New +$3.95M
FZT
143
DELISTED
FAST Acquisition Corp. II
FZT
$3.96M 0.09%
+387,780
New +$3.93M
COP icon
144
ConocoPhillips
COP
$140B
$3.96M 0.09%
+39,873
New +$4.36M
LGVC
145
DELISTED
LAMF Global Ventures Corp. I Class A Ordinary Shares
LGVC
$3.95M 0.09%
+378,097
New +$3.92M
SVNA
146
DELISTED
7 Acquisition Corp
SVNA
$3.95M 0.09%
+378,097
New +$3.92M
DEVS
147
DELISTED
DevvStream Corp
DEVS
$3.93M 0.09%
+37,810
New +$3.9M
JAZZ icon
148
Jazz Pharmaceuticals
JAZZ
$16.7B
$3.93M 0.09%
+26,824
New +$3.97M
ARTE
149
DELISTED
Artemis Strategic Investment Corporation Class A Common Stock
ARTE
$3.91M 0.09%
+378,097
New +$3.89M
MBSC
150
DELISTED
M3-Brigade Acquisition III Corp.
MBSC
$3.91M 0.09%
+378,097
New +$3.88M

Similar funds

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 623 positions worth $4.22B, up 177% from $1.52B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor deployed $3.76B of net new capital in Q1 2023, opening 593 new positions and adding to 5 existing holdings. Its largest new stake was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Activision Blizzard, an estimated $196M trimmed.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited Signify Health, Inc. in Q1 2023, selling an estimated $161M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 593 new positions and closed 3 in Q1 2023.
  • UBS O'Connor's portfolio value rose 177% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.